# Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema

> **NCT02609165** · PHASE2 · COMPLETED · sponsor: **Ospedale San Raffaele** · enrollment: 45 (actual)

## Conditions studied

- Retinitis Pigmentosa
- Cystoid Macular Edema

## Interventions

- **DRUG:** rhNGF 180 µg/ml eye drops solution
- **DRUG:** vehicle eye drops

## Key facts

- **NCT ID:** NCT02609165
- **Lead sponsor:** Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02609165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02609165, "Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02609165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*